We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Portable Device Counts Leukocytes Through the Skin

By LabMedica International staff writers
Posted on 13 Oct 2015
Print article
Image: A portable microscope which is placed manually on the patient’s fingertip to take videos of microcirculation in very superficial capillaries (Photo courtesy of Research Laboratory of Electronics / MIT).
Image: A portable microscope which is placed manually on the patient’s fingertip to take videos of microcirculation in very superficial capillaries (Photo courtesy of Research Laboratory of Electronics / MIT).
A novel way to count white blood cells without a blood test, simply by applying a small device on the fingertip, is being developed.

The technology, which combines an optical sensor with algorithms, has already three prototypes on the go and is specially designed to be used on chemotherapy patients, who could know their immune system levels in real time.

A collaboration between scientific centers and hospitals in the region of Madrid with the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) and other centers in the Boston area (MA, USA), observed that immunosuppression (low white blood cell counts) is the main side effect for chemotherapy patients, which leads to possible infections, hospitalizations, treatment delays and shorter life expectancy.

The team is developing a portable device capable of counting white blood cells in real time, without requiring a blood test. The system includes an innovative optics sensor through the skin that can observe white cells as they flow past a miniature lens. This new device, potentially on the market in 2019, could be applied to improve the treatment of patients who are left immunosuppressed after chemotherapy treatments and to prevent sepsis.

The device is placed on the patient's fingertip, in a similar way to how pulse oximeters are used in hospitals to measure blood oxygen levels. With a small lens, the system captures images of capillaries very close to the surface in the nailbed. When illuminating at certain frequencies, light is absorbed by the hemoglobin in the red cells, an effect that does not happen with the white cells. This means that the leukocytes appear as small transparent particles moving inside the capillary.

There are currently three different prototypes. One of them is a portable microscope which is placed manually on the patient's finger to take videos of their microcirculation in very superficial capillaries. This device has already been tested on 31 patients in a Spanish hospital and on six more in Massachusetts General Hospital. A second version of the prototype includes modifications to the microscope to improve the stability and quality of the images. The third one is a small optical piece which can be added to a mobile phone camera to obtain images of the circulation in the capillaries.

Carlos Castro-Gonzalez, PhD, a bioengineer, said, “The new device will allow white blood cells to be measured simply and painlessly. The same way diabetics nowadays have a glucometer to check their glucose levels; patients undergoing chemotherapy will be able to use a 'leukometer' in the future to estimate the state of their immune system. In rural areas where access to health centers is limited, or in developing countries, this becomes a huge advantage. It would also be possible to perform measurements on a continuous basis, opening up treatment options that were previously not possible.” The study was presented at the Annual International Conference of the IEEE Engineering in Medicine and Biology Society held during August 25–29, 2015, in Milan (Italy).

Related Links:

Massachusetts Institute of Technology 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.